Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, Oc
by from Morbidity and Mortality Weekly Report (MMWR) on (#6X5AB)
This report describes RSV-associated hospitalization rates among infants and young children during the 2024-25 respiratory virus season.